Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Annette Hasenburg Prof., Dr, med
Annette Hasenburg Prof., Dr, med Advisory Board
Sara Tolaney MD, MPH
Sara M. Tolaney MD, MPH Advisory Board
Eric Jonasch MD
Eric Jonasch MD Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · April 03, 2022

Nivolumab in Previously Treated Patients With Advanced Esophageal Squamous Cell Carcinoma

Clinical Cancer Research

 

 Save  Recommend
 Share

Additional Info

Clinical Cancer Research
Three-year follow-up and response-survival relationship of nivolumab in previously treated patients with advanced esophageal squamous cell carcinoma (ATTRACTION-3)
Clin. Cancer Res 2022 Mar 16;[EPub Ahead of Print], M Okada, K Kato, BC Cho, M Takahashi, CY Lin, K Chin, S Kadowaki, MJ Ahn, Y Hamamoto, Y Doki, CC Yen, Y Kubota, SB Kim, CH Hsu, E Holtved, I Xynos, Y Matsumura, A Takazawa, Y Kitagawa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated